tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

COCP Stock Latest News

Cocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
Press ReleasesCocrystal Pharma Reports Favorable Results from Single-Ascending Dose Cohorts of Phase 1 Study with CDI-988, its Oral Pan-Viral Norovirus/Coronavirus Protease Inhibitor
23h ago
COCP
Cocrystal Pharma’s Promising Antiviral Candidate for Influenza A
PremiumCompany Announcements
Cocrystal Pharma’s Promising Antiviral Candidate for Influenza A
29d ago
8K
COCP
Cocrystal Pharma: CC-42344 inhibits activity in ighly pathogenic avian flu
PremiumThe Fly
Cocrystal Pharma: CC-42344 inhibits activity in ighly pathogenic avian flu
29d ago
COCP
New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows
PremiumPress Releases
New Broad-Spectrum Antiviral Currently in a Phase 2a Clinical Trial in Influenza A may be Effective Against the H5N1 Avian Influenza Strain Identified in Humans Exposed to Infected Dairy Cows
29d ago
COCP
Cocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
PremiumThe Fly
Cocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
2M ago
COCP
Cocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
PremiumThe FlyCocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
2M ago
COCP
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
PremiumPress Releases
Cocrystal Pharma Reports First Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
2M ago
COCP
Cocrystal Pharma (COCP) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Cocrystal Pharma (COCP) Q1 Earnings Cheat Sheet
2M ago
COCP
Cocrystal announces completion of enrollment in Phase 2a study of CC-42344
PremiumThe Fly
Cocrystal announces completion of enrollment in Phase 2a study of CC-42344
3M ago
COCP
Cocrystal Pharma Advances Promising Influenza A Drug
PremiumCompany Announcements
Cocrystal Pharma Advances Promising Influenza A Drug
3M ago
8K
COCP
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
PremiumPress Releases
Enrollment Completed in Phase 2a Study with Cocrystal Pharma’s Oral Antiviral Candidate CC-42344 for Pandemic and Seasonal Influenza
3M ago
COCP
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
PremiumPress Releases
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
4M ago
COCP
Cocrystal Pharma sees cash runway beyond next 12 months
PremiumThe FlyCocrystal Pharma sees cash runway beyond next 12 months
4M ago
COCP
Cocrystal Pharma reports 2023 EPS ($1.87), consensus ($2.09)
PremiumThe Fly
Cocrystal Pharma reports 2023 EPS ($1.87), consensus ($2.09)
4M ago
COCP
Cocrystal Pharma Advances Influenza A Treatment Development
PremiumCompany Announcements
Cocrystal Pharma Advances Influenza A Treatment Development
4M ago
8K
COCP
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
PremiumPress Releases
Cocrystal Pharma Receives Pre-IND Responses from the FDA on Oral CC-42344 for Treating Influenza A
4M ago
COCP
Cocrystal Pharma receives pre-IND responses from FDA on oral CC-42344
PremiumThe Fly
Cocrystal Pharma receives pre-IND responses from FDA on oral CC-42344
4M ago
COCP
Is COCP a Buy, Before Earnings?
PremiumPre-Earnings
Is COCP a Buy, Before Earnings?
4M ago
COCP
Cocrystal Pharma provides update on development of CDI-988, CC-42344
PremiumThe Fly
Cocrystal Pharma provides update on development of CDI-988, CC-42344
7M ago
COCP
Cocrystal Pharma price target lowered to $10 from $12 at H.C. Wainwright
PremiumThe FlyCocrystal Pharma price target lowered to $10 from $12 at H.C. Wainwright
7M ago
MRK
COCP
Cocrystal Pharma announces first-patient-in for Phase 2a study of CC-42344
PremiumThe Fly
Cocrystal Pharma announces first-patient-in for Phase 2a study of CC-42344
8M ago
COCP
Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A
PremiumPress Releases
Cocrystal Pharma Announces First-Patient-In for Phase 2a Human Challenge Study Evaluating Oral CC-42344 in Pandemic and Seasonal Influenza A
8M ago
COCP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >